4th Aug Daily Current Affairs Analysis for UPSC Prelims & Mains 2020

Dear Aspirants
IASbhai 4th Aug Daily Current Affairs Analysis for UPSC | Prelims & Mains 2020 is an initiative to dilute major articles from leading Newspapers in India which are most relevant to UPSC preparation –‘THE HINDU, LIVEMINT , INDIAN EXPRESS’ and help millions of readers who find difficulty in answer writing and making notes everyday. Hence we choose articles on daily basis and analyse them with respect to UPSC PRELIMS 2020.

“There is no chance, no destiny, no fate, that can hinder or control the firm resolve of a determined soul.” –Ella Wheeler Wilcox


ORANGE COLOUR: Important for Prelims.

RED COLOUR: Important for Mains.


BLUE COLOUR : Important Links/Survey.

PINK COLOUR: Reports/Themes/Summits.


Antibiotic administration


Antibiotic administration prevalent in COVID-19 patients with no bacterial infection: Study

      WHY IN NEWS:

The proportion of COVID-19 patients with bacterial infections turned out to be 7.1 per cent.

SYLLABUS COVERED: GS 3 : AMR ( Anti-Microbial Resistance )


The COVID-19 pandemic has resulted in the rampant use of antibiotics in the diseased patients to treat bacterial co-infections or rule out the possibility of secondary infections


Clinical Microbiology and Infection


  • Bacterial co-infections are relatively low in patients hospitalised with novel coronavirus disease (COVID-19).
  • A classification on the basis of patient population yielded that bacterial infection ranged from 5.8 per cent in all hospitalised patients to 8.1 per cent in critically-ill patients (those admitted in intensive care units) and 11.6 per cent in fatal cases.

The common bacterial pathogens reported by the studies included MycoplasmaHaemophilus influenzae and Pseudomonas aeruginosa.

      IASbhai WINDUP: 

The administered antibiotics were broad-spectrum, with the majority belonging to the fluoroquinolone and carbapenem classes.

  • Bacterial co-infections are known to be responsible for increased morbidity and mortality in viral respiratory infections.
  • However, their prevalence in COVID-19 patients is not well understood.
  • It is a huge concern in view of the growing antimicrobial resistance (AMR), a global public health threat.
     SOURCES:THE HINDU & PIB | 4th Aug Daily Current Affairs Analysis for UPSC | Prelims & Mains 2020

Serum Institute gets nod for Oxford vaccine trials


Coronavirus update: Serum Institute gets nod for Oxford vaccine trials

      WHY IN NEWS:

The Drugs Controller General of India gave its greenlight to the Serum Institute of India, Pune for conducting Phase 2 and 3 human clinical trials for a vaccine candidate for the novel coronavirus disease (COVID-19) developed by the University of Oxford, London.

SYLLABUS COVERED: GS 3:Health:Diseases


India now accounts for nearly a tenth of the global number of COVID-19 cases, as the country reaches the 1.8 million mark


  • The number of active cases were at 579,357 as of August 3- Union Ministry of Health and Family Welfare.
  • The number of those discharged was at 1,186,203, while 38,135 died from the disease.
  • The total number of cases across the world were 17,660,523, with 262,929 fresh cases added as of August 2- World Health Organization.
  • The total number of deaths were 680,894, with 5,851 deaths recorded as of August 2, according to the data.
  • The number of cases as of August 3, according to worldometers.info, however, was 18,240,633.
  • This means India now accounts for nearly a tenth in the number of global COVID-19 cases.

General insurance companies, including standalone health insurers, reported an over 240 per cent jump in claims for the treatment of the disease over the previous month.

      IASbhai WINDUP: 

Around 71,423 people claimed Rs 1,145.87 crore from insurance companies for treatment of COVID-19.

     SOURCES:THE HINDU & PIB | 4th Aug Daily Current Affairs Analysis for UPSC | Prelims & Mains 2020

DISCOVER MORE : Important Daily Current Affairs for UPSC PRELIMS 2020

If you liked this article, then please subscribe to our YouTube Channel for Daily Current Affairs , Editorial Analysis & Answer writing video tutorials. You can also find us on Twitter and Facebook.

You May Also Like